Digestive Diseases and Sciences

, Volume 51, Issue 7, pp 1226–1229 | Cite as

Betaine Resolves Severe Alcohol-Induced Hepatitis and Steatosis Following Liver Transplantation

  • Karim Samara
  • Chen Liu
  • Consuelo Soldevila-Pico
  • David R. Nelson
  • Manal F. Abdelmalek


betaine liver transplantation alcohol-induced hepatitis fatty liver steatohepatitis insulin resistance antioxidants 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tome S, Lucey MR: Timing of liver transplantation in alcoholic cirrhosis. J Hepatol 39(3):302–307, 2003PubMedCrossRefGoogle Scholar
  2. 2.
    Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55(7):434–438, 1980PubMedGoogle Scholar
  3. 3.
    Wanless IR, Shiota K: The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 24(1):99–106, 2004PubMedCrossRefGoogle Scholar
  4. 4.
    You M, Crabb DW: Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol 287(1):G1–G6, 2004PubMedCrossRefGoogle Scholar
  5. 5.
    Tilg H, Diehl AM: Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 16343(20):1467–1476, 2000CrossRefGoogle Scholar
  6. 6.
    Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ: Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29:664–669, 1999PubMedCrossRefGoogle Scholar
  7. 7.
    Poonawala A, Nair SP, Thuluvath PJ: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32:689–692, 2000PubMedCrossRefGoogle Scholar
  8. 8.
    Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U: Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 33:1098–1104, 2002PubMedCrossRefGoogle Scholar
  9. 9.
    Molloy RM, Komorowski R, Varma RR: Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation. Liver Transpl Surg 3:177–178, 1997PubMedCrossRefGoogle Scholar
  10. 10.
    Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ: Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 7:363–373, 2001PubMedCrossRefGoogle Scholar
  11. 11.
    Barak AJ, Beckenauer HC, Tuma DJ: Dietary betaine promotes generation of hepatic s-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin Exp Res 17:552–555, 1993PubMedCrossRefGoogle Scholar
  12. 12.
    Abdelmalek M, Angulo P, Jorgensen R, Sylvestre P, Lindor K: Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study. Am J Gastroenterol 96:2711–2717, 2001PubMedCrossRefGoogle Scholar
  13. 13.
    Miglio F, Rovati LC, Santoro A, Setkikar I: Efficacy and safety of oral betaine glucurontate in non-alcoholic steatohepatitis. Arzneumittelforchung/Drug Res 50:722–727, 2000Google Scholar
  14. 14.
    Morrison LM: Results of betaine treatment for atherosclerosis. Am J Dig Dis 19:381–382, 1952PubMedCrossRefGoogle Scholar
  15. 15.
    Wickens DEL, Dudman NPB, Tyrell PA: Homocystinuria due to cystionine B-synthase deficiency. The effects of betaine treatment in pyridoxine-responsive patients. Metabolism 34:1115–1121, 1985CrossRefGoogle Scholar
  16. 16.
    Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85(7):2402–2410, 2000PubMedCrossRefGoogle Scholar
  17. 17.
    Angelico F, Del Ben M, Francioso S, Hurtova M, Battista S, Palmieri GP, Tisone G, Angelico M: Recurrence of insulin resistant metabolic syndrome following liver transplantation. Eur J Gastroenterol Hepatol 15:99–102, 2003PubMedCrossRefGoogle Scholar
  18. 18.
    Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH: Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 4:285–296, 1998PubMedCrossRefGoogle Scholar
  19. 19.
    Basaranoglu M, Acbay O, Sonsuz A: A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol 31:384, 1999PubMedCrossRefGoogle Scholar
  20. 20.
    Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N: Metformin in nonalcoholic steatohepatitis. Lancet 358:8893–8894, 2001CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Karim Samara
    • 1
  • Chen Liu
    • 2
  • Consuelo Soldevila-Pico
    • 3
  • David R. Nelson
    • 3
  • Manal F. Abdelmalek
    • 3
    • 3
  1. 1.Department of Internal Medicine, Hepatology and Nutrition, Section of Hepatobiliary Diseases and Liver TransplantationUniversity of FloridaGainesvilleUSA
  2. 2.Department of Anatomic Pathology and Laboratory Medicine, Hepatology and Nutrition, Section of Hepatobiliary Diseases and Liver TransplantationUniversity of FloridaGainesvilleUSA
  3. 3.Division of Gastroenterology, Hepatology and Nutrition, Section of Hepatobiliary Diseases and Liver TransplantationUniversity of Florida College of MedicineGainesvilleUSA

Personalised recommendations